Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-13
DOI
10.1186/s13046-019-1495-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis
- (2019) Claudio Vernieri et al. ONCOLOGIST
- Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity
- (2019) Thi Thinh Nguyen et al. Scientific Reports
- A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
- (2019) Alice Gerges Geagea et al. Oncotarget
- Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models
- (2019) Ruth E Farmer et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study
- (2019) Rohit Bishnoi et al. Cancer Medicine
- Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells
- (2019) Gastón Amable et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus
- (2018) Marie C. Bradley et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin Induces Apoptosis and Alters Cellular Responses to Oxidative Stress in Ht29 Colon Cancer Cells: Preliminary Findings
- (2018) Paola Sena et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin increases the cytotoxicity of oxaliplatin in human DLD-1 colorectal cancer cells through down-regulating HMGB1 expression
- (2018) Wen-Shih Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two phase-III studies
- (2018) O. Abdel-Rahman Clinical & Translational Oncology
- The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
- (2018) Marilena Petrera et al. BMC CANCER
- MIF/CD74 axis is a target for novel therapies in colon carcinomatosis
- (2017) Fabio Bozzi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis
- (2017) Yoon Suk Jung et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo
- (2017) Nadiar Mussin et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient–Derived Xenografts
- (2017) Nur-Afidah Mohamed Suhaimi et al. MOLECULAR CANCER THERAPEUTICS
- Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells
- (2017) Mohamed A. Abu el Maaty et al. MOLECULAR CARCINOGENESIS
- Design and Characterization of Metformin-Loaded Solid Lipid Nanoparticles for Colon Cancer
- (2016) Ndidi C. Ngwuluka et al. AAPS PHARMSCITECH
- A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme
- (2016) İlhan Elmaci et al. BIOCHEMICAL GENETICS
- Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell lines
- (2016) Mona M. Saber et al. BMC CANCER
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
- (2016) Muhammad R. Khawaja et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer
- (2016) J. K. Paulus et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer
- (2016) Vanessa C. Miranda et al. Clinical Colorectal Cancer
- A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival
- (2016) R. Ramjeesingh et al. Current Oncology
- Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer
- (2016) Bo Young Oh et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
- (2016) Takuma Higurashi et al. LANCET ONCOLOGY
- Protective effect of metformin in an aberrant crypt foci model induced by 1,2-dimethylhydrazine: Modulation of oxidative stress and inflammatory process
- (2016) Heloíza Paranzini Bordini et al. MOLECULAR CARCINOGENESIS
- Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis
- (2016) Zhihong Nie et al. PHARMACEUTICAL BIOLOGY
- Re-sensitization of radiation resistant colorectal cancer cells to radiation through inhibition of AMPK pathway
- (2016) HONGYONG JIN et al. Oncology Letters
- Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case–Control Studies from Italy and Spain
- (2016) Valentina Rosato et al. Frontiers in Oncology
- Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer
- (2015) Tina Fransgaard et al. ANNALS OF SURGICAL ONCOLOGY
- Abstract A21: A Phase IIa trial of metformin for colorectal cancer risk reduction among patients with a history of colorectal adenomas and elevated body mass index
- (2015) Jason A. Zell et al. Cancer Prevention Research
- Metformin use and survival after colorectal cancer: A population-based cohort study
- (2015) Úna C. Mc Menamin et al. INTERNATIONAL JOURNAL OF CANCER
- Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition
- (2015) VeronicaL Martinez Marignac et al. Journal of Cancer Research and Therapeutics
- Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment andRASMutations in Colorectal Cancer
- (2015) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- AMPK/p53 Axis Is Essential for α-Lipoic Acid–Regulated Metastasis in Human and Mouse Colon Cancer Cells
- (2015) Sunmi Park et al. JOURNAL OF INVESTIGATIVE MEDICINE
- No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK
- (2015) Bernd Kowall et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells
- (2015) Cheng-Chia Tsai WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells
- (2015) Camille Loubière et al. Oncotarget
- Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis
- (2015) M. Balsells et al. BMJ-British Medical Journal
- Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis
- (2015) M. Balsells et al. BMJ-British Medical Journal
- Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the warburg effect
- (2015) Yanglei Jia et al. Cancer Medicine
- Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin
- (2015) Silvia Cufi et al. Oncotarget
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Colorectal cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metformin for primary colorectal cancer prevention in patients with diabetes: A case-control study in a US population
- (2014) Amikar Sehdev et al. CANCER
- Combined Use of Vitamin D3 and Metformin Exhibits Synergistic Chemopreventive Effects on Colorectal Neoplasia in Rats and Mice
- (2014) W. Li et al. Cancer Prevention Research
- Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
- (2014) Konstantinos K. Tsilidis et al. DIABETES CARE
- Metformin, cancer and glucose metabolism
- (2014) Barbara Salani et al. ENDOCRINE-RELATED CANCER
- Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents
- (2014) Minh Truong Do et al. FREE RADICAL BIOLOGY AND MEDICINE
- Metformin in Patients With Type 2 Diabetes and Kidney Disease
- (2014) Silvio E. Inzucchi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer
- (2014) Pratima Nangia-Makker et al. PLoS One
- Role of Metformin in Suppressing 1,2-Dimethylhydrazine-Induced Colon Cancer in Diabetic and Non-Diabetic Mice: Effect on Tumor Angiogenesis and Cell Proliferation
- (2014) Dalia K. Zaafar et al. PLoS One
- Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
- (2014) Farshad Forouzandeh et al. Journal of the American Heart Association
- Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study
- (2014) Majken Cardel et al. Cancer Medicine
- Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer
- (2013) K. M. J. De Bruijn et al. BRITISH JOURNAL OF SURGERY
- Diabetes, metformin use, and colorectal cancer survival in postmenopausal women
- (2013) Furha Iram Cossor et al. Cancer Epidemiology
- Antidiabetic Medications and the Risk of Colorectal Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis
- (2013) S. Singh et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Cohort Study of Metformin Exposure and Survival in Patients with Stage I-III Colorectal Cancer
- (2013) S. Spillane et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Adiponectin and metformin additively attenuate IL1β-induced malignant potential of colon cancer
- (2013) Hyun-Seuk Moon et al. ENDOCRINE-RELATED CANCER
- Activation of AMP-Activated Protein Kinaseαand Extracelluar Signal-Regulated Kinase Mediates CB-PIC-Induced Apoptosis in Hypoxic SW620 Colorectal Cancer Cells
- (2013) Sung-Yun Cho et al. Evidence-based Complementary and Alternative Medicine
- Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: Could metformin help?
- (2013) Mohamad Nasir Shafiee et al. GYNECOLOGIC ONCOLOGY
- Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
- (2013) Dora Colussi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy
- (2013) Mehulkumar K. Kanadiya et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer
- (2013) Seong-Joon Koh et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
- (2013) Bindiya Thakkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Contextual inhibition of fatty acid synthesis by metformin involves glucose-derived acetyl-CoA and cholesterol in pancreatic tumor cells
- (2013) Mary Jo Cantoria et al. Metabolomics
- Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
- (2013) Monica Franciosi et al. PLoS One
- Metformin use and improved response to therapy in rectal cancer
- (2013) Heath D. Skinner et al. Cancer Medicine
- Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
- (2012) C R Garrett et al. BRITISH JOURNAL OF CANCER
- Use of Metformin Is Not Associated with a Decreased Risk of Colorectal Cancer: A Case-Control Analysis
- (2012) M. Bodmer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Diabetes mellitus and cancer risk: Review of the epidemiological evidence
- (2012) Kentaro Shikata et al. CANCER SCIENCE
- Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus
- (2012) H. Qiu et al. DIABETES OBESITY & METABOLISM
- Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer
- (2012) Jin Ha Lee et al. DIGESTIVE AND LIVER DISEASE
- Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan
- (2012) Chin-Hsiao Tseng EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
- (2012) Chia-Hsuin Chang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diet and Nutrient Factors in Colorectal Cancer Risk
- (2012) Ashley J. Vargas et al. NUTRITION IN CLINICAL PRACTICE
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
- (2011) Z.-J. Zhang et al. DIABETES CARE
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
- (2010) K. Hosono et al. Cancer Prevention Research
- Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
- (2010) Carolyn Algire et al. ENDOCRINE-RELATED CANCER
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase
- (2010) Kunihiro Hosono et al. MOLECULAR CARCINOGENESIS
- Insulin resistance and hyperinsulinaemia in the development and progression of cancer
- (2009) Ian F. Godsland CLINICAL SCIENCE
- Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
- (2009) Morris E Feldman et al. PLOS BIOLOGY
- PTEN and the PI3-Kinase Pathway in Cancer
- (2008) Nader Chalhoub et al. Annual Review of Pathology-Mechanisms of Disease
- The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
- (2008) M. Zakikhani et al. Cancer Prevention Research
- Metformin suppresses intestinal polyp growth in ApcMin/+ mice
- (2008) Ayako Tomimoto et al. CANCER SCIENCE
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
- Metformin versus Insulin for the Treatment of Gestational Diabetes
- (2008) Janet A. Rowan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Comparative lesion sequencing provides insights into tumor evolution
- (2008) S. Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started